PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer

Published:2024 Issue:4 Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Yuan Hua¹^ORCID,Xiu Lin¹^ORCID,Li Ning¹^ORCID,Li Yifan¹^ORCID,Wu Lingying¹^ORCID,Yao Hongwen¹^ORCID

Affiliation:

1. Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e51

Reference34 articles.

1. Cancer Statistics, 2021

2. Cancer incidence and mortality in China, 2016

3. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

4. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

5. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP